{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:42:20Z","timestamp":1785897740660,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772916"],"award-info":[{"award-number":["81772916"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Jiangsu Bureau of Science and Technology"},{"name":"CAMS Innovation Fund for Medical Sciences"}],"content-domain":{"domain":["clinicalkey.jp","jdsjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jdermsci.2018.06.011","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T14:07:21Z","timestamp":1530626841000},"page":"317-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression"],"prefix":"10.1016","volume":"91","author":[{"given":"Hao","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2018.06.011_bib0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.suc.2014.07.013","article-title":"Epidemiology, risk factors, prevention, and early detection of melanoma","volume":"94","author":"Azoury","year":"2014","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.fsc.2012.11.007","article-title":"Melanoma","volume":"21","author":"Ingraffea","year":"2013","journal-title":"Facial Plast. Surg. Clin. North Am."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11912-008-0067-y","article-title":"Melanoma and the tumor microenvironment","volume":"10","author":"Villanueva","year":"2008","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1189\/jlb.1204712","article-title":"Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes","volume":"78","author":"Schutyser","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","article-title":"CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3","volume":"19","author":"Chen","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0035","doi-asserted-by":"crossref","first-page":"e53068","DOI":"10.1371\/journal.pone.0053068","article-title":"CC-chemokine ligand 18 induces epithelial to mesenchymal transition in lung cancer A549 cells and elevates the invasive potential","volume":"8","author":"Ploenes","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.patbio.2015.07.001","article-title":"Chemokine C-C motif ligand 18 expression correlates with tumor malignancy in breast cancer","volume":"63","author":"Gao","year":"2015","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0045","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/mc.22419","article-title":"CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway","volume":"55","author":"Wang","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0050","doi-asserted-by":"crossref","first-page":"230183","DOI":"10.1155\/2014\/230183","article-title":"CC chemokine ligand 18 correlates with malignant progression of prostate cancer","volume":"2014","author":"Chen","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2490-13-42","article-title":"Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection","volume":"13","author":"Miyake","year":"2013","journal-title":"BMC Urol."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0060","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1111\/j.1468-3083.2012.04495.x","article-title":"Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis","volume":"27","author":"Miyagaki","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.gastro.2004.05.031","article-title":"Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer","volume":"127","author":"Leung","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-3-319-22539-5_14","article-title":"Acral lentiginous melanoma","volume":"167","author":"Goydos","year":"2016","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0075","first-page":"688","article-title":"Expression of CC chemokine ligand 18 in cutaneous malignant melanoma tissues and its relationship with vascular growth factor and Ki67 antigen expressions","volume":"49","author":"Song","year":"2016","journal-title":"Chin. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0080","first-page":"201101","article-title":"CC-chemokine ligand 18 could be synthesized in human peripheral blood monocytes induced by IL-4","author":"Xin","year":"2011","journal-title":"Chin. Sci. Paper Online"},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0085","first-page":"833","article-title":"Effects of chemokine CCL18 on the proliferation and invasion of a human melanoma cell line A375","volume":"43","author":"Xin","year":"2010","journal-title":"Chin. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1586\/1744666X.2016.1100965","article-title":"miRNAs in melanoma: a defined role in tumor progression and metastasis","volume":"12","author":"Mannavola","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0095","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","article-title":"Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy","volume":"42","author":"Sica","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0100","doi-asserted-by":"crossref","first-page":"e953418","DOI":"10.4161\/21624011.2014.953418","article-title":"Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages","volume":"3","author":"Su","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0105","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3892\/ijo.2014.2794","article-title":"CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma","volume":"46","author":"Meng","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/jcm5070065","article-title":"EMT in breast carcinoma-a review","volume":"5","author":"Felipe","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0115","first-page":"474","article-title":"miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1","volume":"45","author":"Sun","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0120","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3892\/ol.2015.3927","article-title":"miR-128 regulates the apoptosis and proliferation of glioma cells by targeting RhoE","volume":"11","author":"Shang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0125","doi-asserted-by":"crossref","first-page":"e116321","DOI":"10.1371\/journal.pone.0116321","article-title":"Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis","volume":"10","author":"Hauser","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0130","first-page":"473","article-title":"PFKL\/miR-128 axis regulates glycolysis by inhibiting AKT phosphorylation and predicts poor survival in lung cancer","volume":"6","author":"Yang","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0135","first-page":"1564","article-title":"miR-128 modulates hepatocellular carcinoma by inhibition of ITGA2 and ITGA5 expression","volume":"7","author":"Zhao","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0140","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.3892\/or.2015.4251","article-title":"MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1","volume":"34","author":"Wu","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jdermsci.2018.06.011_bib0145","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.26514","article-title":"Treating cancer with microRNA replacement therapy: a literature review","author":"Hosseinahli","year":"2018","journal-title":"J. Cell. Physiol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118302743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118302743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T13:06:38Z","timestamp":1537275998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181118302743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0923181118302743"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.06.011","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}